1. Home
  2. WGSWW vs VLY Comparison

WGSWW vs VLY Comparison

Compare WGSWW & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGSWW
  • VLY
  • Stock Information
  • Founded
  • WGSWW 2017
  • VLY 1927
  • Country
  • WGSWW United States
  • VLY United States
  • Employees
  • WGSWW N/A
  • VLY N/A
  • Industry
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • VLY Major Banks
  • Sector
  • WGSWW Technology
  • VLY Finance
  • Exchange
  • WGSWW Nasdaq
  • VLY Nasdaq
  • Market Cap
  • WGSWW N/A
  • VLY N/A
  • IPO Year
  • WGSWW N/A
  • VLY N/A
  • Fundamental
  • Price
  • WGSWW $0.25
  • VLY $9.60
  • Analyst Decision
  • WGSWW
  • VLY Buy
  • Analyst Count
  • WGSWW 0
  • VLY 13
  • Target Price
  • WGSWW N/A
  • VLY $10.31
  • AVG Volume (30 Days)
  • WGSWW 35.4K
  • VLY 8.6M
  • Earning Date
  • WGSWW 02-18-2025
  • VLY 01-23-2025
  • Dividend Yield
  • WGSWW N/A
  • VLY 4.62%
  • EPS Growth
  • WGSWW N/A
  • VLY N/A
  • EPS
  • WGSWW N/A
  • VLY 0.69
  • Revenue
  • WGSWW $305,450,000.00
  • VLY $1,518,099,000.00
  • Revenue This Year
  • WGSWW N/A
  • VLY N/A
  • Revenue Next Year
  • WGSWW N/A
  • VLY $8.52
  • P/E Ratio
  • WGSWW N/A
  • VLY $13.82
  • Revenue Growth
  • WGSWW 50.79
  • VLY N/A
  • 52 Week Low
  • WGSWW $0.21
  • VLY $6.47
  • 52 Week High
  • WGSWW $0.25
  • VLY $11.10
  • Technical
  • Relative Strength Index (RSI)
  • WGSWW N/A
  • VLY 47.96
  • Support Level
  • WGSWW N/A
  • VLY $9.76
  • Resistance Level
  • WGSWW N/A
  • VLY $10.13
  • Average True Range (ATR)
  • WGSWW 0.00
  • VLY 0.24
  • MACD
  • WGSWW 0.00
  • VLY -0.06
  • Stochastic Oscillator
  • WGSWW 0.00
  • VLY 17.61

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: